News

Svelte Acrobat Bare Metal Stents Svelte Medical Systems Inc

November 9, 2012 — Svelte Medical Systems announced it received conditional approval from the U.S. Food and Drug Administration (FDA) to begin a pivotal study for the Svelte coronary stent...

MiStent Micell Technologies Stents Bioresorbable Clinical Trial Study

November 7, 2012 — Micell Technologies Inc. announced positive data from two clinical studies of its investigational...

November 1, 2012 — InspireMD Inc. announced that its proprietary MGuard embolic protection stent (EPS) was shown to be significantly superior when compared to standard bare metal and drug-eluting...

October 31, 2012 — Boston Scientific Corp. received CE mark approval for the Synergy everolimus-eluting...

DESolve Nx Pivotal Trial Bioresorbable Coronary Stent Elixir Cath Lab

Elixir Medical Corp. announced enrollment completion of the 120-patient, pivotal clinical trial evaluating the safety and efficacy of the DESolve Novolimus-Eluting...

October 23, 2012 — In the DEBATE-SFA trial, researchers found that the use of a paclitaxel drug-eluting balloon (DEB) to widen the artery prior to implanting a self-expanding nitinol stent yielded...

The Transcatheter Cardiovascular Therapeutics (TCT) conference showcases key advancements being made in interventional cardiology, focusing this year on the next generation of drug-eluting stents...

DESolve Bioresorbable Coronary Scaffold System Clinical Trial

Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced six-month clinical,...

Zilver PTX Randomized Controlled Trial Stents Peripheral artery disease (PAD)

Three-year data from the Zilver PTX randomized controlled trial of paclitaxel-eluting stents for femoropopliteal disease from Cook Medical demonstrate 70.7 percent primary patency in the...

Cook Medical Zilver Vena Venous Self-Expanding Stent

Following Health Canada approval, Cook Medical has made the Zilver Vena Venous Self-Expanding Stent available to physicians across Canada. Designed to restore blood flow in obstructed iliofemoral...

October 3, 2012 — Stentys, a medical technology company commercializing the world's first and only self-apposing stent to...

Abbott Bioabsorbable Stent  Absorb

The world’s first drug-eluting bioabsorbable vascular scaffold has been launched and will revolutionize the stent industry. On Sept. 25, 2012, Abbott announced the launch of its drug-eluting...

Boston Scientific Promus Element Plus BTK Stent

Boston Scientific has launched the Promus Element Plus BTK (Below The Knee) everolimus-eluting stent system in European countries for the treatment of certain severe peripheral artery lesions. The...

Abbott bioresorbable Absorb stent BVS

Abbott Vascular began its international launch of the Absorb coronary stent, the world's first drug-eluting bioresorbable vascular scaffold (BVS). It is now widely available across...

September 24, 2012 — Bio DG announced that its patent for a novel metal system, to use as biodegradable material in developing implantable medical devices, was granted by the U.S. Patent Office on...

MRI Systems Clinical Trial/Study Stents Cath Lab Health Service Research

September 18, 2012 — Inpatient hospital treatment accounts for the largest proportion of healthcare spending in the United States, with the use of diagnostic imaging services such as magnetic...

The Cardiovascular Research Foundation (CRF) announced the late-breaking trials and first report investigations that will be presented at next month's ...

September 6, 2012 — Drug-eluting stents (DES) are used less often in women treated with percutaneous coronary...

August 22, 2012 — Authors of an article in the Journal of Endovascular Therapy have evaluated the effectiveness of endovascular brachytherapy using liquid beta-emitting rhenium-...